Knuettel Francis II insider trades: Pelthos Therapeutics (PTHS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Knuettel reports to the SEC
and 7 more companies
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | PTHS | ↓ Sell | 1,500 | $26.84 | $40K | By Lara Knuettel Revocable Trust | May 26, 2026 (4d) |
| Sep 13, 2024 | CHRO | ↑ Buy | 5,200 | $0.97 | $5K | By Lara Knuettel Revocable Trust | Sep 16, 2024 (3d) |
| Sep 11, 2024 | CHRO | ↑ Buy | 12,000 | $0.91 | $11K | By Lara Knuettel Revocable Trust | Sep 12, 2024 (1d) |
| Jun 18, 2018 | AQMS | ↑ Buy | 7,500 | $3.01 | $23K | Direct | Jun 18, 2018 (0d) |
| May 27, 2008 | FPND.OB | ↑ Buy | 2,500 | $0.60 | $2K | Indirect | May 28, 2008 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PTHS insiders
Open-market trades in the last 12 months
About Knuettel Francis II's insider trades
Knuettel Francis II is CFO, Treas & Secty at Pelthos Therapeutics (PTHS). Since May 27, 2008, Knuettel has reported 4 open-market purchases worth $40K and 1 sale worth $40K on SEC Form 4. In the last 12 months: 1 sale ($40K).
Their filings also include grants and awards (28 filings), gifts (2 filings), shares returned to the company (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PTHS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.